“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Resu…

The 52-week symptom data reported for Cohort 6 patients is consistent with the long-term durability data previously reported ...

This senator's 2 ‘critical’ bills would block Congress' paychecks during shutdown — gutsy move or Constitutional foul?

Thanks to Jeff Bezos, you can now become a landlord for as little as $100 — and no, you don't have to deal with tenants or fix freezers. Here's how Robert Kiyosaki says this 1 asset will surge 400% in ...

SciBase: Interim report

September 30, 2025 The third quarter in figures Net sales were TSEK 10,339 (8,408), +23%, cleared for currency effects +29%.